NRT Smoking Cessation Aids - Australia

June 2010 | 36 pages | ID: N2EF8A350B3EN
Euromonitor International Ltd

Abstracts

The National Preventative Health Strategy, as part of an initiative set up by a federal government task force in 2008, focused on reducing tobacco use as part of the plan to tackle chronic diseases. The strategy released during 2009 outlined recommendations such as increasing tobacco taxes, adopting plain cigarette packaging and implementing more campaigns to reduce passive smoking. The task force looked to reduce smoking prevalence from 19% in 2009 to 9% by 2020.

Euromonitor International's NRT Smoking Cessation Aids Products in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health industry;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Executive Summary
Consumer Health Maintained Steady Growth
H1n1 Influenza Rapidly Developed During the 2009 Winter
Sanofi-aventis Healthcare Pty Ltd Gained Leadership in Consumer Health
Grocery Retailers and Direct Selling Gained Distribution Share
Consumer Health Sales Growth Expected To Hold Steady Over the Forecast Period
Key Trends and Developments
Consumer Health Spending Unabated by Economic Downturn
Fear of H1n1 Influenza Pandemic Facilitated Sales
Grocery Retailers Channel Intensifies Competition for Retail Distribution Share
National Preventative Health Strategy
Ageing Profile of Australian Consumers
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Penetration of Private Label by Sector 2004-2009
  Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2008-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Blackmores Ltd
Strategic Direction
Key Facts
Summary 3 Blackmores Ltd: Key Facts
Summary 4 Blackmores Ltd: Operational Indicators 2007-2009
Company Background
Production
Summary 5 Blackmores Ltd: Production Statistics 2009
Competitive Positioning
Summary 6 Blackmores Ltd: Competitive Position 2009
Ego Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
Summary 7 Ego Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
Summary 8 Ego Pharmaceuticals Pty Ltd: Production Statistics 2009
Competitive Positioning
Summary 9 Ego Pharmaceuticals Pty Ltd: Competitive Position 2009
Herron Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
Summary 10 Herron Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
Summary 11 Herron Pharmaceuticals Pty Ltd: Production Statistics 2009
Competitive Positioning
Summary 12 Herron Pharmaceuticals Pty Ltd: Competitive Position 2009
Inova Pharmaceuticals (australia) Pty Ltd
Strategic Direction
Key Facts
Summary 13 iNova Pharmaceuticals (Australia) Pty Ltd: Key Facts
Company Background
Production
Summary 14 iNova Pharmaceuticals (Australia) Pty Ltd: Production Statistics 2009
Competitive Positioning
Summary 15 iNova Pharmaceuticals (Australia) Pty Ltd: Competitive Position 2009
Swisse Natural Health Products Pty Ltd
Strategic Direction
Key Facts
Summary 16 Swisse Natural Health Products Pty Ltd: Key Facts
Company Background
Production
Summary 17 Swisse Natural Health Products Pty Ltd: Production Statistics 2008
Competitive Positioning
Summary 18 Swisse Natural Health Products Pty Ltd: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Category Indicators
  Table 12 Number of Smokers by Gender 2004-2009
Category Data
  Table 13 Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
  Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
  Table 15 NRT Gum Flavours: % Value Breakdown 2006-2009
  Table 16 Smoking Cessation Aids Company Shares by Value 2005-2009
  Table 17 Smoking Cessation Aids Brand Shares by Value 2006-2009
  Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2009-2014
  Table 19 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2009-2014